BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shingleton HM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol. 1989;73:1027-1034. [PMID: 2726106 DOI: 10.1097/00006250-198906000-00024] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Donati OF, Lakhman Y, Sala E, Burger IA, Vargas HA, Goldman DA, Andikyan V, Park KJ, Chi DS, Hricak H. Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration. Eur Radiol 2013;23:2906-15. [DOI: 10.1007/s00330-013-2875-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
2 Mayr NA, Yuh WT, Jajoura D, Wang JZ, Lo SS, Montebello JF, Porter K, Zhang D, McMeekin DS, Buatti JM. Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer. Cancer 2010;116:903-12. [PMID: 20052727 DOI: 10.1002/cncr.24822] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
3 Holtz DO, Dunton C. Traditional management of invasive cervical cancer. Obstet Gynecol Clin North Am 2002;29:645-57. [PMID: 12509089 DOI: 10.1016/s0889-8545(02)00023-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
4 Yoo HJ, Lim MC, Seo SS, Kang S, Yoo CW, Kim JY, Park SY. Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea. J Gynecol Oncol 2012;23:242-50. [PMID: 23094127 DOI: 10.3802/jgo.2012.23.4.242] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
5 Friedlander M, Grogan M. Guidelines for the Treatment of Recurrent and Metastatic Cervical Cancer. The Oncologist 2002;7:342-7. [DOI: 10.1634/theoncologist.2002-0342] [Cited by in Crossref: 140] [Cited by in F6Publishing: 69] [Article Influence: 7.4] [Reference Citation Analysis]
6 Boers A, Arts HJ, Klip H, Nijhuis ER, Pras E, Hollema H, Wisman GBA, Nijman HW, Mourits MJ, Reyners AK, de Bock GH, Thomas G, van der Zee AG. Radical Surgery in Patients With Residual Disease After (Chemo)Radiation for Cervical Cancer. Int J Gynecol Cancer 2014;24:1276-85. [DOI: 10.1097/igc.0000000000000171] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
7 Beitler JJ, Anderson PS, Wadler S, Runowicz CD, Hayes MK, Fields AL, Sood B, Goldberg GL. Pelvic exenteration for cervix cancer: Would additional intraoperative interstitial brachytherapy improve survival? International Journal of Radiation Oncology*Biology*Physics 1997;38:143-8. [DOI: 10.1016/s0360-3016(96)00585-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Carmen MG, Mcintyre JF, Goodman A. The Role of Intraoperative Radiation Therapy (IORT) in the Treatment of Locally Advanced Gynecologic Malignancies. The Oncologist 2000;5:18-25. [DOI: 10.1634/theoncologist.5-1-18] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
9 Höckel M, Dornhöfer N. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. The Lancet Oncology 2006;7:837-47. [DOI: 10.1016/s1470-2045(06)70903-2] [Cited by in Crossref: 124] [Cited by in F6Publishing: 14] [Article Influence: 8.3] [Reference Citation Analysis]
10 Wydra D, Emerich J, Sawicki S, Ciach K, Marciniak A. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience. World J Gastroenterol 2006;12:1115-9. [PMID: 16534855 DOI: 10.3748/wjg.v12.i7.1115] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
11 Ota T, Takeshima N, Tabata T, Hasumi K, Takizawa K. Adjuvant hysterectomy for treatment of residual disease in patients with cervical cancer treated with radiation therapy. Br J Cancer 2008;99:1216-20. [PMID: 18854823 DOI: 10.1038/sj.bjc.6604619] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
12 de Wilt JH, van Leeuwen DH, Logmans A, Verhoef C, Kirkels WJ, Vermaas M, Ansink AC. Pelvic exenteration for primary and recurrent gynaecological malignancies. European Journal of Obstetrics & Gynecology and Reproductive Biology 2007;134:243-8. [DOI: 10.1016/j.ejogrb.2006.07.025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
13 Ferron G, Pomel C, Martinez A, Narducci F, Lambaudie E, Marchal F, Rouanet P, Querleu D. Exentération pelvienne : actualités et perspectives. Gynécologie Obstétrique & Fertilité 2012;40:43-7. [DOI: 10.1016/j.gyobfe.2011.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
14 Berek JS, Howe C, Lagasse LD, Hacker NF. Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA. Gynecologic Oncology 2005;99:153-9. [DOI: 10.1016/j.ygyno.2005.05.034] [Cited by in Crossref: 170] [Cited by in F6Publishing: 116] [Article Influence: 10.6] [Reference Citation Analysis]
15 Sardain H, Lavoué V, Laviolle B, Henno S, Foucher F, Levêque J. Prognostic Factors for Curative Pelvic Exenterations in Patients With Recurrent Uterine Cervical or Vaginal Cancer: . International Journal of Gynecological Cancer 2014;24:1679-85. [DOI: 10.1097/igc.0000000000000288] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
16 Ungar L, Palfalvi L, Novak Z. Primary pelvic exenteration in cervical cancer patients. Gynecol Oncol 2008;111:S9-12. [PMID: 18775558 DOI: 10.1016/j.ygyno.2008.07.041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
17 Mogor O, Hargrave E, Rush D, Hatch K. Mucinous adenocarcinoma of the endometrium with metastasis to the clitoral glans after pelvic exenteration for radiation resistant vaginal cuff recurrence. Gynecol Oncol Rep 2019;27:46-9. [PMID: 30627614 DOI: 10.1016/j.gore.2018.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Whitcomb BP. Gynecologic Malignancies. Surgical Clinics of North America 2008;88:301-17. [DOI: 10.1016/j.suc.2008.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
19 Marnitz S, Köhler C, Müller M, Behrens K, Hasenbein K, Schneider A. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecologic Oncology 2006;103:1023-30. [DOI: 10.1016/j.ygyno.2006.06.027] [Cited by in Crossref: 87] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
20 del Carmen MG, Eisner B, Willet CG, Fuller AF. Intraoperative radiation therapy in the management of gynecologic and genitourinary malignancies. Surgical Oncology Clinics of North America 2003;12:1031-42. [DOI: 10.1016/s1055-3207(03)00086-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
21 Hatch KD, Gelder MS, Soong S, Baker VV, Shingleton HM. Pelvic exenteration with low rectal anastomosis: Survival, complications, and prognostic factors. Gynecologic Oncology 1990;38:462-7. [DOI: 10.1016/0090-8258(90)90092-y] [Cited by in Crossref: 59] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
22 Waggoner SE. Cervical cancer. Lancet 2003;361:2217-25. [PMID: 12842378 DOI: 10.1016/S0140-6736(03)13778-6] [Cited by in Crossref: 581] [Cited by in F6Publishing: 208] [Article Influence: 32.3] [Reference Citation Analysis]
23 Patel H, Joseph JV, Amodeo A, Kothari K. Laparoscopic salvage total pelvic exenteration: Is it possible post-chemo-radiotherapy? J Minim Access Surg. 2009;5:111-114. [PMID: 20407571 DOI: 10.4103/0972-9941.59310] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
24 Berger JL, Ramirez PT. Surgical management of cervical carcinoma. Hematol Oncol Clin North Am 2012;26:63-78. [PMID: 22244662 DOI: 10.1016/j.hoc.2011.10.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
25 Köhler C, Tozzi R, Possover M, Schneider A. Explorative laparoscopy prior to exenterative surgery. Gynecol Oncol 2002;86:311-5. [PMID: 12217753 DOI: 10.1006/gyno.2002.6764] [Cited by in Crossref: 48] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
26 Gadducci A, Tana R, Cosio S, Cionini L. Treatment options in recurrent cervical cancer (Review). Oncol Lett 2010;1:3-11. [PMID: 22966247 DOI: 10.3892/ol_00000001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
27 Baiocchi G, Guimaraes G, Rosa Oliveira R, Kumagai L, Faloppa C, Aguiar S, Begnami M, Soares F, Lopes A. Prognostic factors in pelvic exenteration for gynecological malignancies. European Journal of Surgical Oncology (EJSO) 2012;38:948-54. [DOI: 10.1016/j.ejso.2012.07.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
28 Benn T, Brooks RA, Zhang Q, Powell MA, Thaker PH, Mutch DG, Zighelboim I. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years. Gynecol Oncol 2011;122:14-8. [PMID: 21444105 DOI: 10.1016/j.ygyno.2011.03.003] [Cited by in Crossref: 60] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
29 Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, Soliman PT. Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration. Gynecol Oncol. 2018;149:484-490. [PMID: 29622276 DOI: 10.1016/j.ygyno.2018.03.054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Matsuo K, Mandelbaum RS, Adams CL, Roman LD, Wright JD. Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study. Gynecol Oncol 2019;153:368-75. [PMID: 30792003 DOI: 10.1016/j.ygyno.2019.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
31 Matsuo K, Matsuzaki S, Mandelbaum RS, Matsushima K, Klar M, Grubbs BH, Roman LD, Wright JD. Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies. J Surg Oncol 2019. [PMID: 31746006 DOI: 10.1002/jso.25770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 Potter ME, Alvarez RD, Gay FL, Shingleton HM, Soong S, Hatch KD. Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer. Gynecologic Oncology 1990;37:74-7. [DOI: 10.1016/0090-8258(90)90311-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
33 Hope JM, Pothuri B. The role of palliative surgery in gynecologic cancer cases. Oncologist 2013;18:73-9. [PMID: 23299775 DOI: 10.1634/theoncologist.2012-0328] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
34 Guimarães GC, Baiocchi G, Ferreira FO, Kumagai LY, Fallopa CC, Aguiar S, Rossi BM, Soares FA, Lopes A. Palliative pelvic exenteration for patients with gynecological malignancies. Arch Gynecol Obstet 2011;283:1107-12. [DOI: 10.1007/s00404-010-1544-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
35 Vargas HA, Burger IA, Donati OF, Andikyan V, Lakhman Y, Goldman DA, Schöder H, Chi DS, Sala E, Hricak H. Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration. Int J Gynecol Cancer 2013;23:1512-9. [PMID: 24257566 DOI: 10.1097/IGC.0b013e3182a41e61] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 3.6] [Reference Citation Analysis]
36 Ghaemmaghami F, Saleh-Gargari S, Sahebdel B, Behtash N, Samiei F. Risk factors and clinical aspects of recurrent invasive cervical carcinoma. J Obstet Gynaecol India 2012;62:674-8. [PMID: 24293846 DOI: 10.1007/s13224-012-0227-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
37 Meterissian SH, Skibber JM, Giacco GG, El-naggar AK, Hess KR, Rich TA. Pelvic exenteration for locally advanced rectal carcinoma: Factors predicting improved survival. Surgery 1997;121:479-87. [DOI: 10.1016/s0039-6060(97)90100-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Haddock MG, Martinez-monge R, Petersen IA, Wilson TO. Locally Advanced Primary and Recurrent Gynecologic Malignancies. In: Gunderson LL, Willet CG, Harrison LB, Calvo FA, editors. Intraoperative Irradiation. Totowa: Humana Press; 1999. pp. 397-419. [DOI: 10.1007/978-1-59259-696-6_22] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
39 Saunders N. Pelvic exenteration: by whom and for whom? The Lancet 1995;345:5-6. [DOI: 10.1016/s0140-6736(95)91146-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
40 Morita K. Cancer of the Cervix. In: Vahrson HW, editor. Radiation Oncology of Gynecological Cancers. Berlin: Springer Berlin Heidelberg; 1997. pp. 143-239. [DOI: 10.1007/978-3-642-60334-1_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Maggioni A, Roviglione G, Landoni F, Zanagnolo V, Peiretti M, Colombo N, Bocciolone L, Biffi R, Minig L, Morrow CP. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol 2009;114:64-8. [PMID: 19411097 DOI: 10.1016/j.ygyno.2009.03.029] [Cited by in Crossref: 101] [Cited by in F6Publishing: 76] [Article Influence: 8.4] [Reference Citation Analysis]
42 Iglesias DA, Westin SN, Rallapalli V, Huang M, Fellman B, Urbauer D, Frumovitz M, Ramirez PT, Soliman PT. The effect of body mass index on surgical outcomes and survival following pelvic exenteration. Gynecol Oncol 2012;125:336-42. [PMID: 22261299 DOI: 10.1016/j.ygyno.2012.01.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
43 Barney BM, Petersen IA, Dowdy SC, Bakkum-Gamez JN, Klein KA, Haddock MG. Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer. Radiat Oncol 2013;8:80. [PMID: 23566444 DOI: 10.1186/1748-717X-8-80] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.9] [Reference Citation Analysis]
44 Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, Ramondetta LM, Bodurka DC, Ramirez PT, Soliman PT. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol 2014;134:546-51. [PMID: 25014540 DOI: 10.1016/j.ygyno.2014.06.034] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 6.9] [Reference Citation Analysis]
45 Monk BJ, Tewari KS. Invasive Cervical Cancer. Clinical Gynecologic Oncology. Elsevier; 2007. pp. 55-124. [DOI: 10.1016/b978-032303978-9.50006-x] [Cited by in Crossref: 8] [Article Influence: 0.6] [Reference Citation Analysis]